Vincerx Pharma, Inc.
Price Action
Technical Summary
DOWNTRENDVincerx Pharma, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 28), showing significant lag compared to the market leaders. Earnings growth of 55% provides fundamental context to the price action. Investors should exercise caution due to high volatility (168% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.01 | -0.78% | BELOW |
| 50 SMA | $0.01 | -1.55% | BELOW |
| 100 SMA | $0.01 | -1.55% | BELOW |
| 150 SMA | $0.01 | -3.79% | BELOW |
| 200 SMA | $0.02 | -37.75% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is VINC in an uptrend right now?
VINC has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is VINC overbought or oversold?
VINC's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.
Is VINC outperforming the market?
VINC has a Relative Strength (RS) Rating of 28 out of 99. VINC is currently lagging the broader market.
Where is VINC in its 52-week range?
VINC is trading at $0.01, which is 17% of its 52-week high ($0.07) and 16% above its 52-week low ($0.00).
How volatile is VINC?
VINC has a Beta of 1.46 and 52-week volatility of 168%. It's more volatile than the S&P 500 - expect bigger swings.